Xizang Haisco Pharma Completes $127 Million IPO
Published: Jan 17, 2012
January 17, 2012 -- Xizang Haisco Pharmaceutical Group, which produces TCM drug formulations and active pharmaceutical ingredients, completed a $127 million IPO on Shenzhen’s Small and Medium-Sized Enterprises Board. The company, located in China’s autonomous Tibet region, is the 11th Tibetan entity to become publicly owned. CITIC Securities was the lead underwriter. More details....
Stock Symbol: (SHE: 002653)